NCI (01336): Zhang Xiufen's Director Appointment Pending Regulatory Approval

Stock News
2025/12/24

NCI (01336) announced that the proposal regarding the election of directors for the ninth board of directors has been formally approved by shareholders. According to relevant Chinese laws and regulations, Ms. Zhang Xiufen's director appointment is still subject to regulatory approval. Until her qualification is approved, Mr. Ma Yaotian, the company's independent non-executive director, will continue to perform his duties in compliance with laws, regulations, and the company's articles of association.

Ms. Zhang Xiufen will sign a corresponding service agreement with the company, and her term will commence upon regulatory approval of her directorship and last until the end of the ninth board's tenure.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10